MERRF is a problematic disease in the field of the nervous system, clinical performance is complex and often involves multi-system congestion. Early identification and standardization of clinical trials are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can assist in connecting teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of MERRF requires the development of a multi-dimensional treatment plan, which typically includes drug therapy, rehabilitation interventions, and regular follow-up. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the neural system diseases that have previously been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of MERRF. The platform serves a team of nationally and internationally authoritative experts in the field of neural systems aligned with the International Medical Service System of China, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.